Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
5 financial challenges facing the medtech sector
Medtech Dive
Tue, 10/10/23 - 11:50 pm
Medtech
revenue
M&A
spinoffs
funding
IPOs
How biotech IPOs performed in the third quarter
BioPharma Dive
Tue, 10/3/23 - 10:28 am
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought
BioSpace
Mon, 10/2/23 - 10:40 am
IPOs
Lexeo Therapeutics
Abivax
genetic medicine
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Fri, 09/29/23 - 10:22 am
Adlai Nortye
IPOs
Novartis
AN2025
head and neck cancer
solid tumors
Neumora Therapeutics stock surges as Amgen confirmed as major shareholder
Proactive Investors
Thu, 09/28/23 - 10:42 am
Amgen
Neumora
IPOs
Emcure Pharma plans to launch $400-500 million IPO in 2024
Mint
Tue, 09/26/23 - 10:21 am
Emcure Pharmaceuticals
IPOs
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Fierce Biotech
Fri, 09/22/23 - 11:42 am
AbPro
IPOs
SPAC
NASDAQ
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
Sun, 09/17/23 - 09:45 pm
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
RayzeBio, Neumora price some of biotech’s largest IPOs this year
BioPharma Dive
Thu, 09/14/23 - 11:02 pm
IPOs
RayzeBio
Neumora Therapeutics
SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 mln in US IPO
NASDAQ
Tue, 09/12/23 - 10:44 am
Neumora Therapeuticsl
funding
Japan
SoftBank
IPOs
Neumora, a richly funded brain drug developer, readies for an IPO
BioPharma Dive
Sun, 08/27/23 - 04:27 pm
Neumora Therapeutics
IPOs
depression
navacaprant
RayzeBio plans IPO to push radiotherapy 'pipeline-in-a-product' through phase 3
Fierce Biotech
Fri, 08/25/23 - 11:52 am
Rayze Bio
radiotherapy
IPOs
In a year with few biotech IPOs, ‘crossover’ financings are hard to find
BioPharma Dive
Wed, 08/16/23 - 10:00 am
CG Oncology
cancer
IPOs
funding
crossover financing
Fresh off its IPO, Sagimet adds two former Cognoa execs to corner office
Medical Marketing and Media
Sun, 07/23/23 - 12:42 pm
Sagimet Biosciences
IPOs
compliance
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
BioPharma Dive
Fri, 07/21/23 - 10:10 am
IPOs
Turnstone Biologics
cell therapy
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
Tue, 07/18/23 - 11:34 am
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
7 Life Science IPOs in 2023
BioSpace
Wed, 07/12/23 - 09:48 am
IPOs
Intensity Therapeutics
Acelyrin
CytoMed Therapeutics
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Investing.com
Fri, 06/30/23 - 11:47 am
Intensity Therapeutics
oncology
cancer
IPOs
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Sun, 06/25/23 - 09:37 pm
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »